Published in Pediatrics on October 01, 1983
The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH | NCT03384121
Antituberculosis drug-induced hepatotoxicity in children. Pediatr Rep (2011) 0.97
Antituberculosis treatment-induced hepatotoxicity: role of predictive factors. Postgrad Med J (1995) 0.87
Transfer of isoniazid from circulation to breast milk in lactating women on chronic therapy for tuberculosis. Br J Clin Pharmacol (2007) 0.78
Isoniazid-induced severe hepatotoxicity: an infrequent but preventable cause of liver failure in children treated for latent tuberculosis infection. Clin Med Insights Pediatr (2011) 0.75
Rifampin use and safety in hospitalized infants. Am J Perinatol (2015) 0.75
A review of tuberculous meningitis in a Canadian pediatric hospital. Can J Infect Dis (1991) 0.75
Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA (1995) 15.26
Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1991) 8.98
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis (1966) 6.38
Nationwide survey of drug-resistant tuberculosis in the United States. JAMA (1994) 6.14
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med (1994) 5.66
Tuberculosis in the United States. JAMA (1989) 5.12
Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis (1981) 4.77
GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature (1997) 4.49
Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA (1994) 4.44
The new tuberculosis. N Engl J Med (1992) 4.37
Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clin Sci (Lond) (2000) 4.34
Multidrug-resistant tuberculosis. Ann Intern Med (1992) 4.06
Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron (1996) 4.00
The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis (1987) 3.48
Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis (1982) 3.38
Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species. Am Rev Respir Dis (1984) 3.25
Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25
Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis (1978) 3.15
Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis (1990) 2.81
Clinical study of forty-nine patients with malignant melanoma. Cancer (1966) 2.74
USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. Ann Intern Med (1990) 2.68
Tuberculosis morbidity in the United States: final data, 1990. MMWR CDC Surveill Summ (1991) 2.53
Epidemiology of tuberculosis in the United States. Epidemiol Rev (1989) 2.23
Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA (1986) 2.18
Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis (1979) 2.15
The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis (1979) 2.13
Tuberculosis in the 1980s. N Engl J Med (1980) 2.09
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis (1993) 2.07
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice. Antimicrob Agents Chemother (2001) 1.98
The relationship between tuberculosis and silicosis. Am Rev Respir Dis (1978) 1.89
The tuberculin skin test. Am Rev Respir Dis (1982) 1.75
Redistribution and stabilization of cell surface glutamate receptors during synapse formation. J Neurosci (1997) 1.73
Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland. Am Rev Respir Dis (1982) 1.69
The prevalence of tuberculosis and drug resistance among Haitians. N Engl J Med (1982) 1.68
Current tuberculosis screening practices. Am J Public Health (1984) 1.67
Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Intern Med (1976) 1.63
Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci (Lond) (2004) 1.62
Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol (2000) 1.62
The usefulness of phage typing Mycobacterium tuberculosis isolates. Am Rev Respir Dis (1984) 1.58
Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med (1990) 1.57
Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis (1985) 1.56
Extrapulmonary tuberculosis in Oklahoma, 1965 to 1973. Am Rev Respir Dis (1975) 1.54
The epidemiology of tuberculosis in the United States. Semin Respir Infect (1989) 1.52
Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci (1998) 1.46
Treatment of tuberculosis during pregnancy. Am Rev Respir Dis (1980) 1.46
Tuberculosis and acquired immunodeficiency syndrome--Florida. Arch Intern Med (1989) 1.45
Bone marrow cell trafficking following intravenous administration. Br J Haematol (1999) 1.43
Trend in HIV prevalence among tuberculosis patients in Tanzania, 1991-1998. Int J Tuberc Lung Dis (2001) 1.40
Tuberculosis elimination: are we willing to pay the price? Am J Respir Crit Care Med (2001) 1.38
Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice. Am J Respir Crit Care Med (1994) 1.35
The need for epidemic intelligence. Public Health Rep (1996) 1.35
C-myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene (1999) 1.34
Bacille Calmette-Guérin vaccinations and tuberculin skin tests. JAMA (1985) 1.33
An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. AIDS (1996) 1.32
Characterization of excitatory amino acid receptors expressed by embryonic chick motoneurons in vitro. J Neurosci (1986) 1.32
Tuberculosis diagnosed at death in the United States. Chest (1991) 1.31
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice. Am J Respir Crit Care Med (1998) 1.30
A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977. A United States Public Health Service cooperative study. Am Rev Respir Dis (1978) 1.25
Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial. Am Rev Respir Dis (1984) 1.25
Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression. Cancer Res (2001) 1.22
Tuberculosis control among homeless populations. Arch Intern Med (1988) 1.21
U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis. Am Rev Respir Dis (1979) 1.20
Drug-resistant tuberculosis. Am Rev Respir Dis (1991) 1.20
Swine-like influenza virus infection in a Wisconsin farm family. J Infect Dis (1977) 1.20
On the mechanism of acetylcholine receptor accumulation at newly formed synapses on chick myotubes. J Neurosci (1985) 1.19
Pyridoxine supplementation during isoniazid therapy. Tubercle (1980) 1.18
Usefulness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy. Pediatr Infect Dis J (1992) 1.17
The global threat of drug-resistant tuberculosis. N Engl J Med (1998) 1.17
Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR Recomm Rep (1990) 1.16
The epidemiology of tuberculosis in the United States. Implications for diagnosis and treatment. Clin Chest Med (1989) 1.16
Haemonectin, a bone marrow adhesion protein specific for cells of granulocyte lineage. Nature (1987) 1.15
Association between HTLV-III/LAV infection and tuberculosis in Zaire. JAMA (1986) 1.15
Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am Rev Respir Dis (1980) 1.14
Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Public Health Rep (1989) 1.13
Influenza-related mortality. JAMA (1978) 1.13
Enhancing patient compliance with tuberculosis therapy. Clin Chest Med (1989) 1.13
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens. Am J Respir Crit Care Med (2000) 1.13
Respiratory status of surface coal miners in the United States. Arch Environ Health (1977) 1.12
Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest (1975) 1.12
Tuberculosis and the acquired immunodeficiency syndrome. Chest (1986) 1.11
Phorbol diesters stimulate the development of an early murine progenitor cell. The burst-forming unit-megakaryocyte. J Clin Invest (1985) 1.10
Tuberculin skin testing of hospital employees: infection, "boosting," and two-step testing. Am J Infect Control (1984) 1.10
Evaluation of the MycoDot test in patients with suspected tuberculosis in a field setting in Tanzania. Int J Tuberc Lung Dis (1999) 1.09
The good news and the bad news about multidrug-resistant tuberculosis. Clin Infect Dis (1995) 1.09
Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol Biol Cell (1996) 1.07
Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failure. JAMA (1985) 1.07
Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin. Am Rev Respir Dis (1984) 1.07
Disease due to Mycobacterium avium-intracellulare. Chest (1985) 1.06
Drug resistance among previously treated tuberculosis patients, a brief report. Am Rev Respir Dis (1980) 1.05
How much tuberculosis in children must we accept? Am J Public Health (1986) 1.04
Immature Megakaryocytes in the Mouse: Morphology and quantitation by acetylcholinesterase staining. Blood (1981) 1.04
Excitatory synaptic transmission between interneurons and motoneurons in chick spinal cord cell cultures. J Neurosci (1986) 1.02